Clinical effectiveness and analytical quality of a national point of-care testing network for sexually transmitted infections integrated into rural and remote primary care clinics in Australia, 2016–2022: an observational program evaluation
Causer LM, Ward J, Smith K, Saha A, Andrewartha K, Wand H, Hengel, B, Badman SG, Tangey A, Matthews S, Mak D, Gunathilake M, Moore E, Speers D, Persing D, Anderson D, Whiley D, Maher L, Regan D, Donovan B, Fairley C, Kaldor J, Shephard M, and Guy R, on behalf of the TTANGO2 Collaboration. June 10, 2024
External Quality Assessment (EQA) for SARS-CoV-2 RNA Point-of-Care Testing in Primary Healthcare Services: Analytical Performance over Seven EQA Cycles
Matthews SJ, Miller K, Andrewartha K, Milic M, Byers D, Santosa P, Kaufer A, Causer LM, Hengel B, Gow I, Applegate T, Rawlinson WD, Guy R, Shephard M. External Quality Assessment (EQA) for SARS-CoV-2 RNA Point-of-Care Testing in Primary Healthcare Services: Analytical Performance over Seven EQA Cycles. Diagnostics 2024, 14(11), 1106.
Flexible and Innovative Connectivity Solution to Support National Decentralized Infectious Diseases Point-of-Care Testing Programs in Primary Health Services: Descriptive Evaluation Study
Saha A, Andrewartha K, Badman SG, Tangey A, Smith KS, Sandler S, Ramsay S, Braund W, Manoj-Margison S, Matthews SJ, Shephard MD, Guy R, Causer LM. J Med Internet Res 2023;25:e46701.
A decentralised point-of-care testing model to address inequities in the COVID-19 response
Hengel B, Causer LM, Matthews S, Smith K, Andrewartha K, Badman S, Spaeth B, Tangey A, Cunningham P, Saha A, Phillips E, Ward J, Watts C, King J, Applegate T, Shephard M, Guy R. December 23, 2020.
A flexible and innovative connectivity solution to support national decentralised infectious diseases point-of-care testing programs in primary health services in Australia
Saha, A., Andrewartha, K., Badman, S., Tangey, A., Smith, K., Sandler, S., Ramsay, S., Braund, W., Margison, S. M., Matthews, S., Shephard, M., Guy, R., Causer., L. A flexible and innovative connectivity solution to support national decentralised infectious diseases point-of-care testing programs in primary health services in Australia. JMIR Preprints (2023). http://doi.org/10.2196/preprints.46701
External Quality Assessment (EQA) for SARS-CoV-2 RNA Point-of-Care Testing in Primary Healthcare Services: Analytical Performance over Seven EQA Cycles
Matthews SJ, Miller K, Andrewartha K, Milic M, Byers D, Santosa P, Kaufer A, Causer LM, Hengel B, Gow I, Applegate T, Rawlinson WD, Guy R, Shephard M. External Quality Assessment (EQA) for SARS-CoV-2 RNA Point-of-Care Testing in Primary Healthcare Services: Analytical Performance over Seven EQA Cycles. Diagnostics 2024, 14(11), 1106.
Flexible and Innovative Connectivity Solution to Support National Decentralized Infectious Diseases Point-of-Care Testing Programs in Primary Health Services: Descriptive Evaluation Study
Saha A, Andrewartha K, Badman SG, Tangey A, Smith KS, Sandler S, Ramsay S, Braund W, Manoj-Margison S, Matthews SJ, Shephard MD, Guy R, Causer LM. J Med Internet Res 2023;25:e46701.
A decentralised point-of-care testing model to address inequities in the COVID-19 response
Hengel B, Causer LM, Matthews S, Smith K, Andrewartha K, Badman S, Spaeth B, Tangey A, Cunningham P, Saha A, Phillips E, Ward J, Watts C, King J, Applegate T, Shephard M, Guy R. December 23, 2020.
Scaling up sexually transmissible infections point-of-care testing in remote Aboriginal and Torres Strait Islander communities: healthcare workers' perceptions of the barriers and facilitators.
Lafferty, L., Smith, K., Causer, L., Andrewartha, K., Whiley, D., Badman, S. G., Donovan, B., Anderson, L., Tangey, A., Mak, D., Maher, L., Shephard, M., Guy, R. Scaling up sexually transmissible infections point-of-care testing in remote Aboriginal and Torres Strait Islander communities: healthcare workers' perceptions of the barriers and facilitators. Implement Sci Commun 2, 127 (2021). https://doi.org/10.1186/s43058-021-00232-8
From trial to program: TTANGO2 scale-up and implementation sustains STI point-of-care testing in regional and remote Australian Aboriginal health services (poster abstract).
L. Causer et al. STI and HIV World Congress (virtual conference), (July 2021) http://dx.doi.org/10.1136/sextrans-2021-sti.269
Molecular point-of-care testing for chlamydia and gonorrhoea in Indigenous Australians attending remote primary health services (TTANGO): a cluster-randomised, controlled, crossover trial.
R. Guy et al. The Lancet Infectious Diseases (October 2018). https://pubmed.ncbi.nlm.nih.gov/30303108/
Molecular testing for chlamydia and gonorrhoea used at point-of-care in remote primary health care settings: a diagnostic evaluation.
Causer LM, Guy RJ, Tabrizi SN, Whiley D, Speers D, Ward J, Tangey A, Badman SG, Hengel B, Natoli L, Anderson DA, Wand H, Wilson D, Regan DG, Shephard M, Donovan B, Fairley CK, Kaldor JM. Molecular testing for chlamydia and gonorrhoea used at point-of-care in remote primary health care settings: a diagnostic evaluation. Sexually Transmitted Infections (accepted 2018). https://doi.org/10.1136/sextrans-2017-053443
A reliable and easy to transport quality control method for chlamydia and gonorrhoea molecular point of care testing.
Badman SG, Causer LM, Guy R, Wand H, Donovan B, Tabrizi S, Speers D, Shephard MD, Vallely A, Whiley D on behalf of the TTANGO investigators. A reliable and easy to transport quality control method for chlamydia and gonorrhoea molecular point of care testing. Pathology 2018;50: 317-321. https://doi.org/10.1016/j.pathol.2017.09.012
A Qualitative Study of the Acceptability of Molecular Point-Of-Care Testing for Chlamydia and Gonorrhoea to Primary Care Professionals in a Remote High STI Burden Setting.
Natoli L, Guy RJ, Shephard M, Causer L, Badman SG, Hengel B, et al. “I Do Feel Like a Scientist at Times”: A Qualitative Study of the Acceptability of Molecular Point-Of-Care Testing for Chlamydia and Gonorrhoea to Primary Care Professionals in a Remote High STI Burden Setting. PLoS ONE 2015; 10(12): e0145993. http://dx.doi.org/10.1371/journal.pone.0145993
Public health implications of molecular point-of-care testing for chlamydia and gonorrhoea in remote primary care services in Australia: a qualitative study.
Natoli L, Guy RJ, Shephard M, Whiley D, Tabrizi SN, Ward J, Regan DG, Badman SG, Anderson DA, Kaldor J, Maher L on behalf of the TTANGO investigator group. Public health implications of molecular point-of-care testing for chlamydia and gonorrhoea in remote primary care services in Australia: a qualitative study. BMJOpen 2015; 5:e006922. http://doi:10.1136/bmjopen-2014-006922
Chlamydia and gonorrhoea point-of-care testing in Australia: where should it be used?
Natoli L, Guy RJ, Shephard M, Donovan B, Fairley C, Ward J, Regan D, Hengel B, Maher L on behalf of the TTANGO Investigators. Chlamydia and gonorrhoea point-of-care testing in Australia: where should it be used? Sexual Health 2015; 12: 51-58. http://dx.doi.org/10.1071/SH14213
A field evaluation of a new molecular-based point-of-care test for chlamydia and gonorrhoea in remote Aboriginal health services in Australia
Louise Causer, Belinda Hengel, Lisa Natoli, Annie Tangey, Steven Badman, Sepehr Tabrizi, David Whiley, James Ward, John Kaldor, Rebecca Guy and on behalf of the TTANGO investigators; 27 November 2014 https://pubmed.ncbi.nlm.nih.gov/25426655/
Point-of-care testing for chlamydia and gonorrhoea: implications for clinical practice.
Natoli L, Maher L, Shephard M, Hengel B, Tangey A, Badman S, Ward J, Guy R on behalf of the TTANGO investigators. Point-of-care testing for chlamydia and gonorrhoea: implications for clinical practice. PLoS ONE 2014; 9(6): e100518. http://dx.doi.org/10.1371/journal.pone.0100518
A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote communities: Test, Treat And GO- the ‘TTANGO’ trial protocol.
Guy R, Natoli l, Ward J, Causer L, Hengel B, Whiley D, Tabrizi S, Donovan B, Fairley C, Badman S, Tangey A, Wand H, Shephard M, Regan D, Wilson D, Anderson D, Kaldor J. A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote communities: Test, Treat And GO- the ‘TTANGO’ trial protocol. BMC Infectious Diseases 2013; 13: 485. http://doi:10.1186/1471-2334-13-485
Analytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis.
Tabrizi S, Unemo M, Golparian D, Twin J, Limnios A, Lahra M, Guy R, Ward J, Kaldor J, Donovan B, Wilson D, Wand H, Regan, D, Causer L, Hengel B, Natoli L, Anderson D, Whiley D, Shephard M, Fairley, C. Analytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis. Journal of Clinical Microbiology 2013; 51: 1945-1947. https://doi.org/10.1128/jcm.00806-13
